Successful targeted therapy of refractory pediatric ETV6-NTRK3 fusion-positive secretory breast carcinoma Journal Article
| Authors: | Shukla, N.; Roberts, S. S.; Baki, M. O.; Mushtaq, Q.; Goss, P. E.; Park, B. H.; Gundem, G.; Tian, K.; Geiger, H.; Redfield, K.; Behr, G.; Benayed, R.; Zehir, A.; Hechtman, J. F.; Darnell, R. B.; Papaemmanuil, E.; Ladanyi, M.; Ku, N.; Kung, A. L.; Baselga, J.; Drilon, A.; Hyman, D. M. |
| Article Title: | Successful targeted therapy of refractory pediatric ETV6-NTRK3 fusion-positive secretory breast carcinoma |
| Keywords: | immunohistochemistry; adolescent; clinical article; human tissue; gene mutation; human cell; promoter region; histopathology; case report; doxorubicin; fluorouracil; recommended drug dose; gemcitabine; paclitaxel; lymph node metastasis; lymph node dissection; gene; carboplatin; dacarbazine; multiple cycle treatment; cyclophosphamide; ifosfamide; docetaxel; axillary lymph node; lung metastasis; breast carcinoma; fusion gene; telomerase reverse transcriptase; mesna; molecularly targeted therapy; bangladesh; tert gene; human; female; priority journal; article; whole genome sequencing; ntrk3 gene; vinorelbine tartrate; larotrectinib; etv6 gene; etv6 ntrk3 gene |
| Journal Title: | JCO Precision Oncology |
| Volume: | 2017 |
| Issue: | 1 |
| ISSN: | 2473-4284 |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2017-12-01 |
| Language: | English |
| DOI: | 10.1200/po.17.00034 |
| PROVIDER: | scopus |
| PMCID: | PMC5880290 |
| PUBMED: | 29623306 |
| DOI/URL: | |
| Notes: | The MSK Cancer Center Support Grant (P30 CA008748) is acknowledge in the PDF -- Corresponding authors is MSK author: Neerav Shukla -- Source: Scopus |
